Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.240
-0.030 (-2.36%)
At close: Jun 27, 2025, 4:00 PM
1.230
-0.010 (-0.81%)
After-hours: Jun 27, 2025, 7:38 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.06 million as of June 27, 2025. Its market cap has decreased by -48.79% in one year.
Market Cap
3.06M
Enterprise Value
-1.16M
1-Year Change
-48.79%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $3.06M, a decrease of -99.97%. That is a compound annual growth rate of -84.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 3.11M | -14.56% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.60B |
| Johnson & Johnson | 368.73B |
| AbbVie | 329.31B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 280.92B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 234.67B |
| AstraZeneca | 215.99B |